Molina-GarcĂa, Laura
Giraldo, Rafael
Article History
Received: 18 January 2017
Accepted: 5 September 2017
First Online: 19 September 2017
Competing Interests
: A patent on the fusions between amyloidogenic sequence repeats and RF1 and their usage for the screening of anti-amyloidogenic compounds has been filed at the European Patent Office (PCT/EP2016/057543).